encapsulation, biodistribution, pharmaceutics, targeted therapies, gambogic acid, GE11 peptide, formulation and dosage form development, transient modulation, ROESY NMR spectroscopy, bioaccessibility, polymeric micelle, pharmacological Inhibitors of HIF-1 and STAT3, nanoparticles, Vitamin D, drug discovery, EGFR-targeted therapy, translational research, clinical trials, doxorubicin, dissolution, drug development, permeation enhancers, Canada, plant, primary central nervous system lymphomas, photostabilizers, head and neck squamous cell carcinoma, mouse models, drug delivery systems, melphalan, hypoxia-induced chemoresistance, skin, virus, circadian clock, child friendly formulation, adenanthin, co-delivery, canola oil deodorizer distillate, Metaplex, innovation, controlled drug delivery, nifedipine, radiolabeling, amphotericin B, biological barriers, blood-brain barrier (BBB), biologicals, lipid nanoparticles, oral formulation, phytosterols, medical devices, chronotherapy, oral, cationic gemini surfactant, route of administration, drug delivery, intra-arterial chemotherapy, developing world, sustained delivery, water miscible solvents, combination therapy, antibodies, throughput, magnetic fields, liposomes, medulloblastoma, drug-resistant melanoma, rosmarinic acid, topical formulation, TNO gastrointestinal model, gastrointestinal simulator, malignant gliomas, transdermal drug delivery, oral delivery, precision medicine, 3D spheroid, flavonoids, staurosporine, DOX-Vit D, loading gradients, bacteriophage, phospholipid complex, triggered drug release, HIF-1, phage display, pharmacokinetics, emulsion, quercetin, cisplatin, parasitic infections, remote loading, HAV6 cadherin peptide, blood-brain barrier, inclusion complex, tocopherols, STAT3, ultrasound, liposome, fungal infections, magnetic resonance imaging (MRI), MG63, model orange juice, radiation, cancer, mefloquine, small molecules, Drug Delivery Systems -- Canada